Pharsight® services improve drug development decision-making and efficiency through offerings from two complementary business units:
Strategic Consulting Services (SCS)
Pharsight SCS is an established global team of scientific, clinical and technical experts dedicated to using model-based drug development (MBDD) to strengthen the quality, visibility, and value of critical development decisions.
Reporting and Analysis Services (RAS)
Pharsight RAS is an expert team of scientific, clinical and technical professionals dedicated to producing the preclinical and clinical study analyses and reports that are the basis of your regulatory submission package.